Raleigh, NC – Caidya has announced the appointment of Michael Clay as Chief Operating Officer. About Caidya: Caidya is a global, mid-sized Contract Research Organization (CRO) that collaborates with biopharmaceutical innovators to accelerate the development of breakthrough therapies for patients with unmet medical needs. The company operates as a product development partner, aiming to integrate seamlessly with sponsors while providing ownership, transparency, and agility to complex clinical programs. Caidya boasts a distinct global footprint, with a direct presence in over 20 countries and conducting studies across more than 50 countries and regions, including strong capabilities in the Americas, Europe, and Asia-Pacific, particularly in China. This cross-border strength allows sponsors to access diverse patient populations and navigate regional regulatory pathways effectively. Caidya specializes in therapeutic areas such as oncology and hematology, rare and pediatric diseases, and other complex indications, emphasizing scientific precision and patient-centric execution. By combining global scale with mid-sized agility, Caidya strives to deliver high-quality data, accelerated timelines, and a superior partnership experience from early development through post-approval.

For more information on Caidya please visit: https://www.caidya.com/

Caidya
2700 Wycliff Rd suite 340
Raleigh, NC 27607
Phone: 919-224-8800
LinkedIn Page: https://www.linkedin.com/company/caidya/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved